Hu, H.; Ramezanpour, M.; Hayes, A.J.; Liu, S.; Psaltis, A.J.; Wormald, P.-J.; Vreugde, S.
Sub-Inhibitory Clindamycin and Azithromycin reduce S. aureus Exoprotein Induced Toxicity, Inflammation, Barrier Disruption and Invasion. J. Clin. Med. 2019, 8, 1617.
https://doi.org/10.3390/jcm8101617
AMA Style
Hu H, Ramezanpour M, Hayes AJ, Liu S, Psaltis AJ, Wormald P-J, Vreugde S.
Sub-Inhibitory Clindamycin and Azithromycin reduce S. aureus Exoprotein Induced Toxicity, Inflammation, Barrier Disruption and Invasion. Journal of Clinical Medicine. 2019; 8(10):1617.
https://doi.org/10.3390/jcm8101617
Chicago/Turabian Style
Hu, Hua, Mahnaz Ramezanpour, Andrew J Hayes, Sha Liu, Alkis J Psaltis, Peter-John Wormald, and Sarah Vreugde.
2019. "Sub-Inhibitory Clindamycin and Azithromycin reduce S. aureus Exoprotein Induced Toxicity, Inflammation, Barrier Disruption and Invasion" Journal of Clinical Medicine 8, no. 10: 1617.
https://doi.org/10.3390/jcm8101617
APA Style
Hu, H., Ramezanpour, M., Hayes, A. J., Liu, S., Psaltis, A. J., Wormald, P.-J., & Vreugde, S.
(2019). Sub-Inhibitory Clindamycin and Azithromycin reduce S. aureus Exoprotein Induced Toxicity, Inflammation, Barrier Disruption and Invasion. Journal of Clinical Medicine, 8(10), 1617.
https://doi.org/10.3390/jcm8101617